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Introduction
The patent foramen ovale (PFO) is a residue of foetal cir-
culation and is found to be patent in approximately 20%−
30% of the adult population. In these subjects there is an
interatrial right-to-left (R-L) shunting when right atrial
pressure exceeds the pressure present in the left atrium.
The association between PFO and stroke and other neuro-
logical diseases has been well documented by both per-
spective and historical studies [1, 2].
Transoesophageal sonography represents the gold
standard for the diagnosis and follow-up of patients suf-
fering from neurological diseases possibly due to
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Abstract In this study we evaluated
the presence of patent foramen ovale
(PFO) in a cohort of 25 consecutive
patients suffering from migraine with
aura (MA) during an attack present-
ing to the emergency ward of an
Italian hospital. Patients underwent
brain magnetic resonance imaging
(MRI) with contrast medium, routine
coagulation tests, contrast transcra-
nial echocolour-coded sonography
(c-TCCS) and transoesophageal
echocardiography (TEE). Of the
enrolled patients, 88.7% showed a
PFO according to the c-TCCS test,
whereas only in 72% TEE confirmed
the presence of PFO. This discor-
dance could be due to the fact that 
c-TCCS is more sensitive even with
shunts with minimal capacity also
located in the pulmonary vascula-
ture. After surgical treatment of the
PFO, MA disappeared within two
months. Also, the treatment with
warfarin as well as with acetylsali-
cylic acid and flunarizine was able to
dramatically reduce the frequency of
migraine attacks. These data indicate
a higher prevalence of PFO in MA
vs. normal population (OR=2.92) and
could suggest that the presence of
arteriovenous (AV) shunts could rep-
resent a trigger for MA attacks as
well as for stroke, but more studies
are needed to confirm this prelimi-
nary hypothesis.
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embolisms from a PFO. This technique can also detect the
morphological features of the shunts, and this is signifi-
cant because the amplitude of the shunt is related to the
embolic entities [3]. Conversely, contract transcranial
Doppler (c-TCD) is the most sensitive method to detect R-
L shunts, the majority of which are due to PFO [4, 5].
A possible relationship between migraine with aura
(MA) and paradoxical embolism caused by PFO has been
reported. A high prevalence of MA is reported in patients
with paradoxical embolism, suggesting a possible role of
this association in the occurrence of cerebrovascular
events [6]. Right-to-left shunts are also associated with
some forms of decompression illness, suggesting the pos-
sibility that these shunts have a role in the aetiology of
MA [7]. These observations suggest that paradoxical gas
embolism may precipitate MA.
Moreover, a closure of PFO in patients with transient
cerebral ischaemia, suffering from MA, induced a dramat-
ic improvement of MA episodes, suggesting that aura may
be triggered by factors that reach the brain by escaping the
lung’s filter [8].
To investigate the prevalence of PFO in patients suf-
fering from MA, we studied a cohort of 27 consecutive
subjects referring to the Emergency Ward of the Reggio
Emilia Hospital during MA attack.
Patients and methods
Patients
Twenty-seven consecutive patients with attacks of MA present-
ing to the Emergency Ward of the Santa Maria Nuova Hospital
of Reggio Emilia, from April to August 2003, complained of
having a MA. Two subjects who refused to undergo the transoe-
sophageal echocardiography (TEE) were excluded from the
study evaluation and only 25 subjects (17 women and 8 men)
were enrolled. The diagnosis of MA fulfilled the ICHD-II crite-
ria [9]. Patients attending this study were well aware of their MA
and followed a number of prophylactic treatments including
beta-blockers, flunarizine and amitriptyline, but never treated
their attacks with acetylsalicylic acid (ASA). We performed the
Italian version of the Migraine Disability Assessment Scale
(MIDAS) for an overall evaluation. After the first visit, all the
patients were given a diary chart to record the number, intensity
and duration of the migraine attacks, and the drugs taken.
Study design
The patients underwent routine examinations in the Emergency
and Neurology Wards, including brain magnetic resonance imag-
ing (MRI) with contrast medium, c-TCCS and a TEE. Coagulation
parameters and blood values were considered in all subjects.
MRI was carried out with a Philips 1-tesla (USA) apparatus.
A positive result was obtained when morphological lesions in T2
record were found, possibly due to recent or past ischaemic
lesions.
The c-TCCS was performed using a Philips-Sonos 5500
device (Andover, MA, USA), exploring the temporal window
with mesoencephalic axial access monitoring the cerebral medi-
um artery [10]. Before the test, both intracranial arteries speedy
measurement and their anatomical aspects locking at arterial-
vein malformations (MAV) or aneurysmatic malformations were
performed. In this last case we performed the examination by
using coronal access in the temporal window.
High-intensity transient signals (HITS) were counted for 25
s after the end of the Valsalva manoeuvre, and the numbers of
HITS were classified in one of four categories (zero HITS, 1−10
HITS, >10 HITS without curtain, and curtain) following the
Blersch method [4].
TEE was performed by using an echocardiograph device
“Philips Sonos 5500” (Andover, MA, USA) equipped with a
multi-frequency probe S3 and transoesophageal multi-polar
probe. The presence of PFO was defined by a R-L shunt at rest
or after a Valsalva procedure after a IV injection of solution of
mixed saline 9 ml plus air 1 ml.
A bolus with this contrast medium was injected into a fore-
arm vein both at rest and in the Valsalva condition. The passage
of more than 3 microemboli in the following three cardiac cycles
was considered a diagnosis for PFO. This procedure was repeat-
ed a maximum of four times [6].
Atrial septal aneurysm was defined as in literature [10]:
– Presence of septal bulging over 10 mm then theoretical sep-
tal plain.
– Basal extension over 15 mm.
The Valsalva manoeuvre was performed by deep breathing
and followed this procedure, according to the international rec-
ommendations of the Consensus Conference [11]:
– Five seconds after injection of saline solution, the patient
began Valsalva manoeuvre lasting for at least ten seconds.
– Test positivity was obtained by the reduction of at least one-
third of the systolic flow velocity on the middle cerebral
artery (MCA).
The Ethical Committee (EC) evaluation was unnecessary
because the patients followed the routine diagnostic-therapeutic
protocol established by the Emergency and Neurology Wards
protocols, which have already been approved by the local EC. All
the patients were informed about the diagnostic procedures and
expressed an explicit consensus. Only two patients refused to
perform the TEE, and therefore were not included in this study.
The prevalence of PFO in the normal population of Reggio
Emilia was explored in a study performed on the general popu-
lation by a sonology specialist at the end of 2000. The study pro-
posed to evaluate the performances of the new Echodoppler
apparatus and to define basic parameters: 44 healthy volunteers
underwent TCCD with contrast medium following the interna-
tional criteria as reported above. These subjects were 19 males
and 27 females, mean age 38.4 years (range 24−56), without any
pathological condition and not suffering from MA. In this group
there were 14 positive cases (30.5%) for a R-L shunt, but only in
5 cases (10.8%) was the shunt large. The data were analysed
using a SPSS package programme.
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Results
Patients’ demographic characteristics are reported in
Table 1. The clinical characteristics of patients’ migraine
are reported in Table 2.
The MRI images were referred to the following cases:
female, 46 years old, assuming oestroprogestinic treatment
(OP) and suffering from MA since the age of 28 years with
a prolonged TR signal (thyroid hormone receptor) in right
caudate; female, 36 years old, non-smoker, no OP, MA
since the age of 18 years, small TR lesion in the left occip-
ital area; female, 43 years old and male 47 years old, non-
smokers, no OP, with diffuse small non-specific lesions.
We presumed cardiovascular risk factors for patients
when one or more of the following were present: smoking
more than 20 cigarettes/day, use of oestroprogestinics and
blood hypertension.
All the enrolled patients underwent both transcranial
and transoesophageal sonography and results are reported
in Table 3. The presence of a number of HITS significant
for arteriovenous (AV) shunts are shown and the concor-
dance of the two analyses are listed in the last column.
Table 1 Characteristics of patients
Patients, n Sex Age, years±SD Onset of aura, years±SD Patients with vascular risk, n Brain positive MRI, n
8 M 42.5±9.8 32.1±11.5 1 1
17 F 38.8±12.05 26.1±11.1 1 3
25 Total number 40.2±11.3 28.1±11.2 2 4
Table 2 Characteristics of patients at the enrolling time
Migraine index Intensity Aura, min Aura type MIDAS
0.03 2 20 Typical 2
0.008 3 35 Typical+sensorial 2
0.5 3 45 Typical 4
0.01 2 18 Typical 2
0.06 2 30 Typical 3
0.01 1 13 Typical+sensorial 3
0.03 2 30 Typical 3
0.28 3 20 Typical 4
0.03 3 60 Basilar-type 3
0.03 3 40 Typical+sensorial 2
0.06 2 25 Typical+sensorial 1
0.01 2 20 Typical 3
0.14 3 20 Typical+sensorial 3
0.1 2 10 Typical 2
0.28 2 10 Typical 2
0.006 3 40 Typical 2
0.005 3 30 Typical+sensorial 3
0.009 2 20 Typical 1
0.03 3 30 Typical+sensorial 2
0.03 2 13 Typical 2
0.1 2 30 Typical+sensorial 4
0.009 3 15 Typical 3
0.01 2 25 Typical+sensorial 4
0.02 3 40 Typical 2
0.001 3 30 Typical+sensorial 2
0.03 3 45 Typical 2
0.06 3 30 Typical 2
Mean 0.07 2.48 27.55 2.51
SD 0.11 0.58 12.11 0.84
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The types of aura reported by patients with PFO were:
typical (13), with aphasia (3), basilar-type (1) and ictal
(2). There was no relationship between the type of aura
and the length of the disease and/or the entity of the PFO
(ANOVA test). There was a strong relationship between
TCCS and TEE positive tests. Only in one case was this
referred to the first aura episode. This patient showed a
large PFO and was surgically treated with complete remis-
sion. In five cases an atrial septal aneurysm was found,
but there were no surgical indications and patients were
treated with ASA.
The follow-up data of the patients are reported in Table 4.
Surgical closure of PFO was always decided after a
cardiosurgery consultation. This procedure was selected
taking into account the patient’s age, the shape of PFO,
the presence of aneurysm, the presence of ischaemic
lesion showed by MRI and an overall evaluation of throm-
bosis risk.
All patients who underwent PFO closure were treated
with ASA. Sporadic episodes of MA, and subsequently no
other episodes of MA were recorded in five patients, treat-
ed surgically with devices implantation, during the first
6–8-week period. A six-month follow-up showed, only in
one case, few migraine attacks and a new sonography
examination with TEE was performed, showing a R-L
shunt probably due to an incomplete closure of the intera-
trium device.
The seven negative patients to the TEE test were
treated with flunarizine 5 mg and ASA 300 mg (one
patient) and with ASA 300 mg/day (six patients). The
overall outcome (no. of attacks) at the 4-month follow-up
was zero attacks for the first patient and 3 attacks for the
other six cases.
Patients treated with surgical device showed clinical
features that were comparable with other cases with
respect to the frequency, intensity of migraine and to the
aura type. The only difference was the complete response
6–8 weeks after the treatment. Considering the four-
month follow-up period, we did not find significant dif-
ferences between treatments, probably because of the
small sample we examined.
Discussion
TCCS could be considered a safe and effective technique
to detect R-L shunts. This method is characterised by the
use of an intravenous infusion of air and saline, shacken
as contrast medium that produces a suspension of micro-
Table 4 Patients’ therapy and follow-up
ASA 300 mg Warfarin ASA 300 mg+flunarizine 5 mg Surgery 4-month outcome
12 <50% of aura attacks
2 No attacks
6 <60% aura attacks
5 No attacks
Doses are indicated as total daily amount
Table 3 Results of sonography tests
n TCCS negative TEE negative TCCS positive TEE positive TEE/TCCS, %
Male 8 1 2 7 6 85.7
Female 17 2 5 15 12 80.0
All 25 3 7 (28%) 22 (88%)* 18 (72%) 81.8**
Control group 46 32 (69.5%) 14 (30.5%)
*OR TCCS<->TEE=0.93
**c2 test=p<0.001 (positive vs. negative)
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emboli with a diameter inferior to red blood cells, but
unable to pass through the lung filter. This medium inject-
ed into a forearm vein goes to the heart and, in case a R-
L shunt is present, it can be detected by a TCCS in the
arterial tree at the level of the MCA, suggesting a possible
PFO or, more infrequent, other AV shunts [10].
The Valsalva manoeuvre enhances the sensitivity of
the test and recent studies comparing the TCCS with the
transoesophageal Doppler (TEE) indicate that the
Valsalva manoeuvre shows a 100% sensitivity in TCCS
vs. TEE and a specificity around 73% [10–13].
In this study we used the TCCS because this method
can immediately exclude concomitant pathologies like AV
congenital malformations, aneurysms and stenosis of
intracranial arteries. Moreover, in these patients it could
be relevant to study the functional densitometry with the
wash in-and-out curves. In fact, the use of new contrast
media allows the study of the secondary harmonic waves
that are related to the parenchyma perfusion, leading to
new and important information on cerebral functions. At
the moment these methods are used only in the study of
cerebral ischaemia to guide the fibrinolytic therapy and
not in the study of MA.
Moreover, TCCS can suggest the dimension and func-
tion of the shunt depending on the number of HITS and
curtains present. When the TCCS patterns show a number
of 1−10 HITS, the diameter of the shunt could be consid-
ered slight; moderate in case of >10 HITS without curtain
effect; and severe when there is a curtain effect. If HITS
are present at rest or after Valsalva manoeuvre, the shunt
could be considered permanent or intermittent after
Valsalva manoeuvre [5, 9, 14, 15].
In this study we examined a cohort of patients with
MA and found that TCCS was positive in about 88% of
patients referring an attack of MA, and TEE was positive
for PFO in 2/3 of the subjects. The concordance of these
two methods was high and significant (p<0.001, χ2 test).
The higher prevalence of PFO vs. normal population
studies was calculated as an odds ratio (odds ratio:
0.1496 Wald 95% CI: 0.2224<O.R.<0.8542 inverse OR
p2<->p1: 2.29 (~SE=0.79)), which showed a significant
difference (p<0.02).
Only in four cases did TEE not confirm the presence of
a PFO. This discordance could be due to the fact that
TCCS is more sensitive, even with shunts with minimal
capacity. The high percent of PFO that we found could be
related to the characteristics of the study cohort of MA
patients attending an emergency ward, which could not be
exactly representative of the whole population of migraine
patients.
Another point that should be discussed is the possible
existence of medium AV shunts at lung level that can
allow the passage of air contrast and therefore the air can
be detected in the brain arteries with TEES and Valsalva
manoeuvre.
The major aim of the study was to confirm the high
prevalence of PFO in MA. It is possible that these two
conditions share a common pathological pathway, but
physiopathological mechanisms underlying this possibil-
ity need further studies. If the complete resolution of
aura symptoms after surgical closure of PFO emerged in
the short-term follow-up at 4 months, in the long-term
the relationship between these two disorders may be
strengthened, even if it is reasonable to think that other
biochemical parameters are involved in the mechanism
of MA.
The hypothesis that there is a disturbance of the blood
perfusion and oxygen supply during an aura episode is
reasonable. There are some reports that hypothesise
microembolic phenomena during stroke [16, 17] and MA
[18−20]. The presence of PFO or atrial septal aneurysm
has been well studied in recurrent cerebrovascular events
(MAS) and the association between PFO and transient
global amnesia (TGA) suggested that intermittent
microemboli in the late vertebrobasilar vessels territory
underlie at least some TGA cases. The prevalence of atri-
al septal aneurysms is significantly higher in patients with
MA compared with patients with migraine without aura
and with control subjects [21]. In this case, a formation of
clots near the aneurysmatic surface which is often riddled
with microscopic holes, or paradoxical embolisation
through a coexisting PFO, or atrial septal defects, or valve
prolapse, or other cardiac abnormalities potentially
responsible for embolism could be hypothesised.
Migraine with sensorial and/or visual aura is another
paroxysmal disturbance where a sudden malfunction of
discrete cortical areas fed by terminal branches of the
basilar artery could trigger the attack. In our opinion the
migrainous aura is a complex syndrome, not always repet-
itive and with different clinical patterns. These differences
could be representative of a variety of pathogenetic mech-
anisms; the spreading depression hypothesis could be
modified in the future by new neuroimaging techniques.
Conversely, at the moment, there are no evident mark-
ers in the selection of patients who should undergo TCCS
examinations and there are no biochemical or clinical ele-
ments related to PFO presence or size. In fact, there was
no relationship between the type or length of aura phe-
nomena and the TCCS or TEE results.
Transcatheter closure of PFO with or without ASA
seems to be a safe, effective, minimally invasive proce-
dure that ensures high closure rate and avoids life-long
anticoagulant administration. It also seems to be an inter-
esting strategy to treat patients with recurrent episodes of
MA, and mid-term follow-up results appear favourable to
prevent recurrent thromboembolism [8].
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The pharmacological treatment seems to be effective
in the same manner even with low doses of ASA and with
treatment with a calcium channel antagonist like flunar-
izine at a dose of 5 mg/day. It was really interesting to
note that the anticoagulant therapy with warfarin was
more effective than other treatments, confirming the
importance of the role played by coagulation and/or
microembolism in the pathogenesis of MA.
In conclusion, our opinion is that MA patients could be
studied with a c-TCCS and in case of positive results
should also subsequently undergo a brain MRI and a TEE
before final diagnosis [19].
Therefore, our results are only preliminary and in con-
cordance with the data obtained by Evans [20]. Further
studies are needed to confirm these data and develop
guidelines for the treatment of patients with MA.
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